Geneesmiddelenbeleid

This procedure involves a general consultation report regarding the Netherlands' pharmaceutical policy. It focuses on how the government manages the availability, pricing, and distribution of medicines to ensure sustainable healthcare and patient access to essential treatments. This affects healthcare providers, pharmaceutical companies, and patients within the Dutch healthcare system through potential changes in drug procurement and pricing regulations.